CA125 Levels in BRCA mutation carriers – a retrospective single center cohort study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CA125 Levels in BRCA mutation carriers – a retrospective single center cohort study
Authors
Keywords
-
Journal
BMC CANCER
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-02
DOI
10.1186/s12885-023-11116-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
- (2022) C. Sessa et al. ANNALS OF ONCOLOGY
- Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2021) Usha Menon et al. LANCET
- CA125 and Ovarian Cancer: A Comprehensive Review
- (2020) Parsa Charkhchi et al. Cancers
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Predicting Circulating CA125 Levels among Healthy Premenopausal Women
- (2019) Naoko Sasamoto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease
- (2019) Michael C. Honigberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis
- (2018) Lei Zhang et al. CURRENT PROBLEMS IN CANCER
- Screening for Ovarian Cancer
- (2018) Jillian T. Henderson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chronic Medical Conditions and CA125 levels among Women without Ovarian Cancer
- (2018) Babatunde O. Akinwunmi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
- (2017) Adam N. Rosenthal et al. JOURNAL OF CLINICAL ONCOLOGY
- Age at natural menopause and its associated factors in Canada
- (2017) Christy Costanian et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis
- (2017) Marco Aurelio Pinho Oliveira et al. Biomed Research International
- Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers
- (2017) Daphne Gschwantler-Kaulich et al. PLoS One
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
- (2016) S. Paluch-Shimon et al. ANNALS OF ONCOLOGY
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Increased Serum Cancer Antigen-125 Is a Marker for Severity of Deep Endometriosis
- (2015) Pietro Santulli et al. Journal of Minimally Invasive Gynecology
- Baseline and post prophylactic tubal–ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers
- (2014) Ying Chen et al. Familial Cancer
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
- (2014) Amy P.M. Finch et al. JOURNAL OF CLINICAL ONCOLOGY
- Costs, Effectiveness, and Workload Impact of Management Strategies for Women With an Adnexal Mass
- (2014) Laura J. Havrilesky et al. JNCI-Journal of the National Cancer Institute
- Comparison of age at natural menopause inBRCA1/2mutation carriers with a non-clinic-based sample of women in northern California
- (2013) Wayne T. Lin et al. CANCER
- Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation
- (2013) Amy Finch et al. FERTILITY AND STERILITY
- Association of BRCA1/2 mutations with FMR1 genotypes: Effects on menarcheal and menopausal age
- (2013) Muy-Kheng M. Tea et al. MATURITAS
- Elevation of CA 125 and CA 19-9 in patients with end-stage liver disease
- (2012) Ashish Singhal et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening in 1077 Women After BRCA Testing
- (2012) Gabriel N. Mannis et al. JAMA Internal Medicine
- A Novel Approach to Predict the Likelihood of Specific Ovarian Tumor Pathology Based on Serum CA-125: A Multicenter Observational Study
- (2011) B. Van Calster et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status
- (2011) S. J. Skates et al. Cancer Prevention Research
- Impact of surgical menopause on lipid and bone metabolism
- (2011) T. Yoshida et al. CLIMACTERIC
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- (2009) Usha Menon et al. LANCET ONCOLOGY
- Increased Risk of Cognitive Impairment or Dementia in Women Who Underwent Oophorectomy Before Menopause
- (2009) W A. Rocca et al. OBSTETRICAL & GYNECOLOGICAL SURVEY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation